Tag: cell banking outsourcing market industry analysis

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Are the Key Projections for the CAGR of the Cell Banking Outsourcing Market Size From 2025 to 2034?#_x000D_

The market size for cell banking outsourcing has seen a fast-paced expansion in recent times. It is set to rise from $11.19 billion in 2024 to $12.86 billion in 2025, projecting a compound annual growth rate (CAGR) of 15.0%. The growth experienced during the historic period is linked to the climb in chronic disease occurrences, heightened government initiatives, regulatory backing and directives, along with a surge in the setting up of banking services._x000D_

_x000D_

The market size for cell banking outsourcing is anticipated to witness a significant rise in the upcoming years. The market is predicted to reach a value of $21.65 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 13.9%. This growth during the predicted period can be owing to the increased use of cellular products, high demand for monoclonal antibodies, a surge in the use of stem cell therapies, an increasing ageing population, and a growing reliance on cell-based therapies. Key trends for the forecast period would encompass product innovations, advancements in technology, investment in research and development, and partnerships between biotech firms and specialized cell banking services._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp_x000D_

_x000D_

#Which Factors and External Forces Are Driving Demand in the Cell Banking Outsourcing Market?#_x000D_

The increasing prevalence of chronic diseases is anticipated to boost the cell banking outsourcing market’s expansion in the future. Chronic diseases are persistent, typically slow-developing conditions that endure over a prolonged period. Lifestyle modifications, growing aging community, and genetic predilections contribute to the escalating prevalence of these chronic diseases. Cell banking outsourcing is instrumental in propelling research and development initiatives to counter chronic diseases by supplying expertise, resources, and infrastructure that might be lacking in-house. For instance, the Department of the Treasury reported in July 2023 that in 2020–21, nearly half of all Australians (46.6%) were diagnosed with one or more chronic diseases, and almost one in five (18.6%) had two or more chronic conditions. Hence, the escalating prevalence of chronic diseases is triggering the expansion of the cell banking outsourcing market._x000D_

_x000D_

#Which Segments in the Cell Banking Outsourcing Offer the Most Growth?#_x000D_

The cell banking outsourcing market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking_x000D_

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking_x000D_

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation_x000D_

_x000D_

Subsegments:_x000D_

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank_x000D_

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank_x000D_

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=15754&type=smp_x000D_

_x000D_

#What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Cell Banking Outsourcing Market?# Market?#_x000D_

North America was the largest region in the cell banking outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#Which Cutting-Edge Market Trends Are Expected to Drive theCell Banking Outsourcing Market’s Growth?#_x000D_

Key players in the cell banking outsourcing market are prioritizing the creation of technologically advanced solutions such as single-cell potency characterization platforms. These platforms allow for an accurate and in-depth evaluation of the potency and functionality of each cell within a cell group. One such company, Cellply Srl, an Italian biotech firm, introduced VivaCyte in January 2024. This product, an end-to-end single-cell potency characterization platform, combines potency analysis and immunophenotyping to expedite cell therapy research and development. VivaCyte is a completely automated, independent platform with single-cell resolution that aims to lessen development durations, expenses, and uncertainties. It does this by rapidly and thoroughly defining the intricate functionality and operation method of potential cellular immunotherapies. Furthermore, this platform facilitates quick testing of numerous cell therapy candidates from different procedure selections against many target tumor cells. It also offers consistent immune cell characterization and single-cell functional characterization in less time than traditional analytical tools require._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report_x000D_

_x000D_

#What Are the Key Elements That Define the Cell Banking Outsourcing Market?#_x000D_

Cell banking outsourcing refers to the practice of contracting external organizations to establish, maintain, and manage repositories of cell lines crucial for various applications in biotechnology and pharmaceutical industries, such as drug discovery and biomanufacturing. It ensures that cells are handled, stored, and maintained under standardized conditions, ensuring consistency and reliability._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15754_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Cell Banking Outsourcing Market Growth Performance Trended Historically, And What Lies Ahead?

The market size for cell banking outsourcing has experienced swift growth in the last few years. It is projected to escalate from $11.19 billion in 2024 to $12.89 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.2%. The growth observed during the historic period can be linked to a surge in chronic illnesses, an uptick in government initiatives, enhanced regulatory support and guidelines, and an increase in banking services establishments.

What Is the Forecast for the Cell Banking Outsourcing Market Size Through 2029?

In the approaching years, the market size for cell banking outsourcing is anticipated to experience swift expansion. The projection reveals an upsurge to $22.39 billion in 2029, with a compound annual growth rate (CAGR) of 14.8%. Factors contributing to the growth during the predicted period include an escalating adoption of cell-based products, increased demand for monoclonal antibodies, a rising trend towards stem cell therapies, an expanding geriatric population, and an increased reliance on cell-based therapies. Significant trends anticipated during the forecast period encompass product innovations, advancements in technology, increased investment in research and development, and partnership initiatives between biotech companies and specialized cell banking services.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

What are the Key Market Players in Cell Banking Outsourcing Market and How They’re Evolving?

Major companies operating in the cell banking outsourcing market are LabCorp Drug Development, SGS Life Sciences, Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Sigma-Aldrich Co. Ltd., Covance Inc., Global Stem Inc., LifeCell, Cryoviva India, Sartorius AG, Bio Reliance, CordLife, Reliance Life Sciences, Cryo-Cell International Inc., Toxikon Corp., Cleancells, Clean Biologics, Texcell, PX’Therapeutics SA, Goodwin Biotechnology Inc., Transcell Biolife Pvt Ltd., Perfectus Biomed Limited, BioStorage Technologies Inc.

What Are the Primary Growth Drivers in the Cell Banking Outsourcing Market?

An increase in chronic diseases is anticipated to spur the expansion of the cell banking outsourcing market. Conditions that persist for a long duration, typically evolving gradually, are known as chronic diseases. Numerous factors contribute to the surge in chronic diseases, such as shifts in lifestyle, increasing age demographics, and genetic proclivities. Cell banking outsourcing significantly contributes to research and development initiatives for chronic diseases, offering access to specialized skills, resources, and infrastructure that may not exist internally. For example, data from the Department of the Treasury, an Australian national treasury and financial department, in July 2023 reveals that in 2020–21, almost half of the Australian population across all age groups (46.6%) were battling one or more chronic diseases, while nearly one in five (18.6%) had two or more ongoing conditions. Consequently, the escalating burden of chronic diseases is propelling the growth of the cell banking outsourcing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15754&type=smp

What Are the Leading Segments in the Global Cell Banking Outsourcing Industry?

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

What Are the Key Market Trends in the Cell Banking Outsourcing Industry?

Leading firms in the cell banking outsourcing sector are concentrating on creating cutting-edge technological solutions like single-cell potency characterization platforms to offer accurate, in-depth analysis of individual cell potency. Such platforms utilize advanced techniques to evaluate and quantify the potency and functionality of individual cells within a cell group. For example, in January 2024, biotech firm Cellply Srl, which is based in Italy, introduced its principal product, VivaCyte. This is an all-encompassing single-cell potency characterization platform that combines potency analysis with immunophenotyping to expedite cell therapy research and development. VivaCyte is a fully independent platform with single-cell resolution, engineered to minimize development duration, expenses, and risks through swift, exhaustive characterization of the intricate functionality and operation mechanism of viable cellular immunotherapies. The platform facilitates speedy testing of numerous cell therapy contenders from a variety of process alternatives against different target tumor cells. This ensures consistent immune cell characterization and single-cell functional characterization, vastly faster than existing analytical tools.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

What Is the Regional Outlook for the Cell Banking Outsourcing Market?

North America was the largest region in the cell banking outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15754

This Report Delivers Insight On:

1. How big is the cell banking outsourcing market, and how is it changing globally?

2. Who are the major companies in the cell banking outsourcing market, and how are they performing?

3. What are the key opportunities and risks in the cell banking outsourcing market right now?

4. Which products or customer segments are growing the most in the cell banking outsourcing market?

5. What factors are helping or slowing down the growth of the cell banking outsourcing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Cell Banking Outsourcing Market Growth Performance Trended Historically, And What Lies Ahead?

The market size for cell banking outsourcing has experienced swift growth in the last few years. It is projected to escalate from $11.19 billion in 2024 to $12.89 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.2%. The growth observed during the historic period can be linked to a surge in chronic illnesses, an uptick in government initiatives, enhanced regulatory support and guidelines, and an increase in banking services establishments.

What Is the Forecast for the Cell Banking Outsourcing Market Size Through 2029?

In the approaching years, the market size for cell banking outsourcing is anticipated to experience swift expansion. The projection reveals an upsurge to $22.39 billion in 2029, with a compound annual growth rate (CAGR) of 14.8%. Factors contributing to the growth during the predicted period include an escalating adoption of cell-based products, increased demand for monoclonal antibodies, a rising trend towards stem cell therapies, an expanding geriatric population, and an increased reliance on cell-based therapies. Significant trends anticipated during the forecast period encompass product innovations, advancements in technology, increased investment in research and development, and partnership initiatives between biotech companies and specialized cell banking services.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

What are the Key Market Players in Cell Banking Outsourcing Market and How They’re Evolving?

Major companies operating in the cell banking outsourcing market are LabCorp Drug Development, SGS Life Sciences, Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Sigma-Aldrich Co. Ltd., Covance Inc., Global Stem Inc., LifeCell, Cryoviva India, Sartorius AG, Bio Reliance, CordLife, Reliance Life Sciences, Cryo-Cell International Inc., Toxikon Corp., Cleancells, Clean Biologics, Texcell, PX’Therapeutics SA, Goodwin Biotechnology Inc., Transcell Biolife Pvt Ltd., Perfectus Biomed Limited, BioStorage Technologies Inc.

What Are the Primary Growth Drivers in the Cell Banking Outsourcing Market?

An increase in chronic diseases is anticipated to spur the expansion of the cell banking outsourcing market. Conditions that persist for a long duration, typically evolving gradually, are known as chronic diseases. Numerous factors contribute to the surge in chronic diseases, such as shifts in lifestyle, increasing age demographics, and genetic proclivities. Cell banking outsourcing significantly contributes to research and development initiatives for chronic diseases, offering access to specialized skills, resources, and infrastructure that may not exist internally. For example, data from the Department of the Treasury, an Australian national treasury and financial department, in July 2023 reveals that in 2020–21, almost half of the Australian population across all age groups (46.6%) were battling one or more chronic diseases, while nearly one in five (18.6%) had two or more ongoing conditions. Consequently, the escalating burden of chronic diseases is propelling the growth of the cell banking outsourcing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15754&type=smp

What Are the Leading Segments in the Global Cell Banking Outsourcing Industry?

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

What Are the Key Market Trends in the Cell Banking Outsourcing Industry?

Leading firms in the cell banking outsourcing sector are concentrating on creating cutting-edge technological solutions like single-cell potency characterization platforms to offer accurate, in-depth analysis of individual cell potency. Such platforms utilize advanced techniques to evaluate and quantify the potency and functionality of individual cells within a cell group. For example, in January 2024, biotech firm Cellply Srl, which is based in Italy, introduced its principal product, VivaCyte. This is an all-encompassing single-cell potency characterization platform that combines potency analysis with immunophenotyping to expedite cell therapy research and development. VivaCyte is a fully independent platform with single-cell resolution, engineered to minimize development duration, expenses, and risks through swift, exhaustive characterization of the intricate functionality and operation mechanism of viable cellular immunotherapies. The platform facilitates speedy testing of numerous cell therapy contenders from a variety of process alternatives against different target tumor cells. This ensures consistent immune cell characterization and single-cell functional characterization, vastly faster than existing analytical tools.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

What Is the Regional Outlook for the Cell Banking Outsourcing Market?

North America was the largest region in the cell banking outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15754

This Report Delivers Insight On:

1. How big is the cell banking outsourcing market, and how is it changing globally?

2. Who are the major companies in the cell banking outsourcing market, and how are they performing?

3. What are the key opportunities and risks in the cell banking outsourcing market right now?

4. Which products or customer segments are growing the most in the cell banking outsourcing market?

5. What factors are helping or slowing down the growth of the cell banking outsourcing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the cell banking outsourcing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Projected CAGR for the Cell Banking Outsourcing Market Size from 2025 to 2034?

In the past few years, there has been a surge in the size of the cell banking outsourcing market. This market is estimated to expand from $11.19 billion in 2024 to $12.89 billion in 2025, with a compound annual growth rate (CAGR) of 15.2%. Factors such as the escalating prevalence of chronic diseases, an uptick in government efforts, regulatory backing and guidelines, as well as the growth of banking services, have all contributed to this historic period growth.

In the coming years, the market size for cell banking outsourcing is projected to experience speedy growth. By 2029, the market is predicted to grow to $22.39 billion, with a compound annual growth rate (CAGR) of 14.8%. The forecast period’s growth can be credited to factors such as the increasing acceptance of cellular products, escalating demand for monoclonal antibodies, burgeoning adoption of stem cell therapies, an aging population, and a growing reliance on cell-based therapies. Notable trends for the forecast period encompass product innovations, technological progress, investment in research and development, and partnerships between biotech firms and specialized cell banking services.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Cell Banking Outsourcing Market?

The escalation in chronic disease prevalence is anticipated to drive the cell banking outsourcing market’s expansion. Chronic ailments are enduring conditions that usually evolve slowly and carry on for a prolonged duration. The surge in such conditions is attributed to various factors like lifestyle alterations, aging demographics, and genetic propensities. Cell banking outsourcing proves critical in enhancing research and development initiatives aimed at combating chronic diseases by offering expertise, resources, and infrastructure not typically available internally. For example, in July 2023, the Department of the Treasury, an Australian national treasury and financial department, stated that in 2020-2021, almost half of all Australians (46.6%) suffered from one or more chronic ailments, while nearly one in five (18.6%) had two or more chronic conditions. As a result, the increasing burden of chronic diseases is fueling the growth of the cell banking outsourcing market.

Which Key Market Segments Comprise the Cell Banking Outsourcing Market and Drive Its Revenue Growth?

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15754&type=smp

Which Areas Are Leading Regions in the Cell Banking Outsourcing Market Expansion Across the Globe?

North America was the largest region in the cell banking outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which Technological Trends Are Reshaping the Cell Banking Outsourcing Industry Dynamics?

Companies that dominate the cell banking outsourcing market are prioritizing the creation of technologically superior solutions, like platforms for single-cell potency characterization, to conduct precise evaluations of the potency of individual cells. A platform for single-cell potency characterization is a complex technology or system of methodologies targeted at assessing the potency and functional abilities of cells within a population. One example is the January 2024 launch of VivaCyte by Cellply Srl, an Italian biotechnology firm. VivaCyte is the company’s key product and a comprehensive single-cell potency characterization platform that merges potency analysis with immunophenotyping to simplify cell therapy research and development. As a fully automated standalone platform, VivaCyte is designed to decrease development durations, costs, and risks through swift and comprehensive characterization of the intricate functionality of potential cellular immunotherapies. The platform expedites the testing of multiple cell therapy candidates against various target tumor cells, offering consistent immune cell characterization and functional characterization at the single-cell level in a time significantly less than that required by currently available analytical tools.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

How Is the Cell Banking Outsourcing Market Conceptually Defined?

Cell banking outsourcing refers to the practice of contracting external organizations to establish, maintain, and manage repositories of cell lines crucial for various applications in biotechnology and pharmaceutical industries, such as drug discovery and biomanufacturing. It ensures that cells are handled, stored, and maintained under standardized conditions, ensuring consistency and reliability.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15754

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Primary Drivers Are Supporting the Continued Market Growth of theCell Banking Outsourcing Market?

The augmentation of chronic illnesses’ weight is anticipated to stimulate the expansion of the cell banking outsourcing market in the near future. Chronic illnesses are enduring issues that usually develop slowly and linger for a prolonged duration. The escalating prevalence of chronic diseases can be ascribed to a mixture of several elements, encompassing lifestyle alterations, elderly populations, and genetic predisposition. Cell banking outsourcing significantly contributes to enhancing research and development endeavors intent on tackling chronic diseases by ensuring access to expertise, resources, and infrastructure that may be inaccessible internally. For example, the Department of the Treasury disclosed in July 2023 that, according to an Australian national treasury and financial department, nearly half of all Australians (46.6%) had one or more chronic illnesses in 2020-21, and nearly one in five (18.6%) had two or more chronic conditions. Hence, the increasing burden of chronic diseases is propelling the cell banking outsourcing market’s growth.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

#What is the Projected CAGR for the Cell Banking Outsourcing Market Size from 2025 to 2034?

The market size for cell banking outsourcing has seen a swift expansion in the past few years. The market’s projected growth will escalate from $11.19 billion in 2024 to $12.89 billion in 2025, with a compound annual growth rate (CAGR) of 15.2%. The historical growth’s driving forces include the escalating prevalence of chronic conditions, an uptick in government initiatives, the presence of supportive regulations and guidelines, and an increase in the establishment of banking services.

Anticipated rapid expansion is predicted for the cell banking outsourcing market size in the forthcoming years, reaching a valuation of $22.39 billion by 2029, accelerating at a compound annual growth rate (CAGR) of 14.8%. Factors for the positive projection in this period include the elevated usage of cellular products, a surge in demand for monoclonal antibodies, increased uptake of stem cell therapies, an aging global population, and increased reliance on cell-based treatments. Noteworthy trends during this forecast period comprise product breakthroughs, technological enhancements, investment in research and innovations, and partnerships between biotech corporations and specific cell banking services.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15754

How Are Consumer Market Innovations Shaping the Current and Future Landscape of theCell Banking Outsourcing Market?

Key players in the cell banking outsourcing market are concentrating their efforts on creating innovative and technologically advanced solutions like single-cell potency characterization platforms. These platforms yield accurate and comprehensive analysis of cell potency at a single-cell level. For instance, in January 2024, Cellply Srl, a biotech firm from Italy, unveiled its flagship product, VivaCyte. VivaCyte is a holistic single-cell potency characterization platform that combines potency analysis with immunophenotyping to simplify cell therapy research and development. The platform is an autonomous, complete system with single-cell resolution, designed to expedite development, lower costs, and mitigate risks by swiftly and thoroughly analyzing the intricate functionality and action mechanisms of potential cellular immunotherapies. VivaCyte aids in the quick testing of multiple cell therapy options from different process alternatives, against various target tumor cells, offering consistent immune cell characterization and single-cell functional analysis in less time than traditional analytic tools.

Who Are the Key Market Players Influencing the Growth of the Corn and Cell Banking Outsourcing Industry?

Major companies operating in the cell banking outsourcing market are LabCorp Drug Development, SGS Life Sciences, Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Sigma-Aldrich Co. Ltd., Covance Inc., Global Stem Inc., LifeCell, Cryoviva India, Sartorius AG, Bio Reliance, CordLife, Reliance Life Sciences, Cryo-Cell International Inc., Toxikon Corp., Cleancells, Clean Biologics, Texcell, PX’Therapeutics SA, Goodwin Biotechnology Inc., Transcell Biolife Pvt Ltd., Perfectus Biomed Limited, BioStorage Technologies Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Which Key Market Segments Comprise the Cell Banking Outsourcing Market and Drive Its Revenue Growth?

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15754&type=smp

Which Regions Are Emerging as Leaders in the Cell Banking Outsourcing Market?

North America was the largest region in the cell banking outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Cell Banking Outsourcing Market 2025, By The Business Research Company:

Fuel Cell Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fuel-cell-global-market-report

Cell Counting Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-counting-global-market-report

Stem Cell Assay Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the cell banking outsourcing market right now?

The cell banking outsourcing market has grown rapidly in recent years. It is expected to rise from $11.19 billion in 2024 to $12.89 billion in 2025, with a compound annual growth rate (CAGR) of 15.2%. The growth drivers include the increase in chronic disease prevalence, government initiatives and regulatory support, and the expansion of banking services.

How fast Is the cell banking outsourcing market expected to grow, and what’s its future value?

The cell banking outsourcing market is projected to reach $22.39 billion by 2029 at a CAGR of 14.8%. Growth is attributed to the rising use of cellular products, demand for monoclonal antibodies, the adoption of stem cell therapies, an aging population, and dependence on cell-based therapies. Trends include product innovations, technological advancements, and biotech companies collaborating with specialized cell banking services.

Get your cell banking outsourcing market report here!

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

What are the leading drivers of growth in the cell banking outsourcing market?

The rising burden of chronic diseases is expected to boost the growth of the cell banking outsourcing market. Chronic diseases, such as heart disease and diabetes, require ongoing management and are becoming more prevalent due to lifestyle changes and aging populations. Outsourcing cell banking services can enhance research and development efforts to address chronic conditions by providing specialized expertise and infrastructure. For example, in July 2023, the Department of the Treasury reported that almost half of Australians (46.6%) had one or more chronic diseases in 2020–21. This rising chronic disease burden will accelerate the growth of the market.

What are the key segments defining the cell banking outsourcing market?

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

Who are the key players steering the development of the cell banking outsourcing market?

Major companies operating in the cell banking outsourcing market are LabCorp Drug Development, SGS Life Sciences, Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Sigma-Aldrich Co. Ltd., Covance Inc., Global Stem Inc., LifeCell, Cryoviva India, Sartorius AG, Bio Reliance, CordLife, Reliance Life Sciences, Cryo-Cell International Inc., Toxikon Corp., Cleancells, Clean Biologics, Texcell, PX’Therapeutics SA, Goodwin Biotechnology Inc., Transcell Biolife Pvt Ltd., Perfectus Biomed Limited, BioStorage Technologies Inc.

What emerging trends are influencing the growth of the cell banking outsourcing market?

In the cell banking outsourcing market, companies are focusing on developing advanced solutions such as single-cell potency characterization platforms. These platforms enable precise analysis of individual cell potency within a population. For instance, in January 2024, Italy-based Cellply Srl launched VivaCyte, a fully automated single-cell potency characterization platform designed to accelerate cell therapy research. This platform provides rapid, reproducible analysis of immune cell functionality and is designed to shorten development times and reduce risks.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15754

Which regions are most influential in expanding the cell banking outsourcing market?

North America was the largest region in the cell banking outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Fuel Cell Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fuel-cell-global-market-report

Cell Counting Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-counting-global-market-report

Stem Cell Assay Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Does the Projected Growth of the Cell Banking Outsourcing Market Compare Over the Forecast Period?

Over the past few years, the cell banking outsourcing market size has expanded rapidly. It’s projected to escalate from a size of $11.19 billion in 2024 to about $12.89 billion in 2025, with a compound annual growth rate (CAGR) of 15.2%. The growth witnessed in the preceding period can be traced back to several factors including an increase in chronic disease prevalence, a surge in government initiative and regulatory support, as well as an expansion in the setting up of banking services.

The market size for cell banking outsourcing is predicted to experience swift expansion in the upcoming years. The market is forecasted to rise to $22.39 billion in 2029, with a compound annual growth rate (CAGR) of 14.8%. The surge during the predicted period can be ascribed to the increased acceptance of cell-related products, growing requirements for monoclonal antibodies, the rise in application of stem cell treatments, an increasing elderly population, and a growing reliance on cell-based therapies. Notable trends during the forecast period encompass product innovation, technological progress, investment in research and development, and partnerships between biotech firms and specific cell banking services.

What External and Internal Drivers Are Contributing to the Growth of the Cell Banking Outsourcing Market’s Growth?

The escalation of chronic diseases is anticipated to drive the expansion of the cell banking outsourcing market in the future. These diseases are enduring conditions that usually onset slowly and continue over a long period. The increasing incidence of these chronic diseases is primarily due to a blend of different elements such as changes in lifestyle, aging population, and genetic predispositions. Cell banking outsourcing plays an indispensable part in pushing forward research and development activities to tackle chronic diseases by offering expertise, resources, and facilities that might not be on hand internally. For example, data from the Department of the Treasury in July 2023 illustrates that an Australian-based national treasury and financial department reported in 2020-21, roughly half of Australians of all age groups (46.6%) were suffering from one or more chronic diseases, and nearly one in five (18.6%) were dealing with two or more chronic health conditions. Consequently, the escalation of chronic diseases fuels the growth of the cell banking outsourcing market.

Explore Comprehensive Insights Into The Global Cell Banking Outsourcing Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

Who Are the Key Players Steering the Development of the Cell Banking Outsourcing Market?

Major companies operating in the cell banking outsourcing market are:

• LabCorp Drug Development

• SGS Life Sciences

• Lonza Group Ltd.

• WuXi AppTec

• Charles River Laboratories

How Are Consumer Trends Shaping the Current and Future Landscape of the Cell Banking Outsourcing Market?

Leading firms in the cell banking outsourcing sector are concentrating on creating technologically superior solutions like single-cell potency characterization platforms. The purpose of such platforms is to offer accurate and comprehensive analysis of individual cell potency. These platforms are intricate technologies or methods intended to evaluate and quantify the potency and functional capacities of single cells within a cell group. For example, in January 2024, VivaCyte was launched by Cellply Srl, an Italian biotech firm. VivaCyte, the firm’s top product, is an all-encompassing single-cell potency characterization platform that amalgamates potency analysis with immunophenotyping to expedite cell therapy research and development. VivaCyte is a fully independent platform that offers single-cell resolution, developed to cut down development times, costs, and risks by quickly and thoroughly identifying the intricate functionality and mechanism of potential cellular immunotherapies. This platform facilitates swift testing of numerous cell therapy candidates from a variety of process options in opposition to multiple target tumor cells, providing consistent immune cell classification and single-cell functional characterization in significantly less time than other existing analytical tools.

Secure Your Global Cell Banking Outsourcing Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Which Key Segments Define the Structure of the Cell Banking Outsourcing Market and Their Growth Potential?

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

Which Geographical Regions Are Shaping the Cell Banking Outsourcing Market Growth?

North America was the largest region in the cell banking outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

How Do Experts Define the Scope of the Cell Banking Outsourcing Market?

Cell banking outsourcing refers to the practice of contracting external organizations to establish, maintain, and manage repositories of cell lines crucial for various applications in biotechnology and pharmaceutical industries, such as drug discovery and biomanufacturing. It ensures that cells are handled, stored, and maintained under standardized conditions, ensuring consistency and reliability.

Browse Through More Similar Reports By The Business Research Company:

Fuel Cell Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fuel-cell-global-market-report

Cell Counting Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-counting-global-market-report

Stem Cell Assay Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: